JG
ORIC icon

Jain Global’s Oric Pharmaceuticals ORIC Stock Holding History

Jain Global’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Buy
+17,637
New +$160K ﹤0.01% 1533
2025
Q4 		– Sell
-15,154
Closed -$182K – 1443
2025
Q3 		$182K Buy
+15,154
New +$159K ﹤0.01% 907

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jain Global's ORIC Position: Q2 2026 in Review

Jain Global opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 17,637 shares worth $191K. The stake represents ﹤0.01% of the portfolio and ranks #1533 among its holdings. This is a return to the name: Jain Global previously reported a position in ORIC as recently as Q3 2025.

Jain Global first reported a position in ORIC in Q3 2025 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Jain Global held 17,637 shares of Oric Pharmaceuticals worth $191K as of Q2 2026.
  • Oric Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1533 holding.
  • Jain Global first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.